CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Phase I Study to Determine the Safety and Pharmacokinetics of JNJ-26483327, a Multi-targeted Kinase Inhibitor, Administered to Subjects With Advanced Stage and/or Refractory Solid Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00676299
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:04.481895+00:00
Published At: 2010-04-26T00:00:00+00:00
Record Updated At: 2010-04-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Protein Kinase Inhibitors", "Antineoplastic Protocols", "Clinical Trial, Phase 1", "Maximum Tolerated Dose", "Pharmacokinetics", "Advanced Malignancies", "Solid Malignancies"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-04-26"
protocolSection.identificationModule.nctId: "NCT00676299"
protocolSection.identificationModule.officialTitle: "An Open-label, Phase I Study to Determine the Safety and Pharmacokinetics of JNJ-26483327, a Multi-targeted Kinase Inhibitor, Administered to Subjects With Advanced Stage and/or Refractory Solid Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.